https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Dry powder formulations of antifungal agents such as itraconazole and voriconazole with favourable physicochemical and aerosol properties are developed using various powder engineering technologies, but it is important to consider their suitability for use in patients with compromised lung functions. In addition, more biological studies on the therapeutic efficacy and pharmacokinetic profile are needed to demonstrate their clinical potential.Leukotrienes are one of the major eicosanoid lipid mediators being produced a